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Objectives: This study aims to quantify the expected years of life lost (EYLL) that 
could be saved if the original Healthy People (HP) 2020 target goal for reducing 
invasive colorectal cancer (CRC) was met. MethOds: A total of 232,208 patients 
diagnosed with invasive CRC in 2000–2011 were identified from the Surveillance, 
Epidemiology, and End Results (SEER) registries. The lifetime survival functions for 
the cancer cohort and age-/sex-matched reference population were generated using 
a semiparametric extrapolation method with annual US life tables from 2000-2011. 
The EYLL for CRC was calculated by subtracting the estimated life expectancy of 
CRC patients from that of the reference population. The total EYLL that could be 
prevented was calculated by subtracting the age-adjusted incidence of invasive CRC 
rate of the base year from that of the target year multiplied by the average EYLL per 
person and the 2020 population projections. Results: An individual diagnosed 
with invasive CRC was estimated to have an average life-expectancy of 10.1 years 
and 6.8 EYLL. If the HP 2020 target goal for invasive CRC was met, the nation could 
potentially save an estimated 154,848 EYLL. For men and women with an invasive 
CRC, estimated EYLL were 74,528 and 79,334, respectively. By race, reducing invasive 
CRC would result in a significantly greater benefit for both black men and women 
compared to white men and women with p< 0.05. The estimated EYLL was 7.4 and 
8.0 years for black men and women and 6.4 and 6.1 years for white men and women 
per person, respectively. cOnclusiOns: The potential life years saved by success-
fully meeting the HP 2020 target for invasive CRC rate would be substantial for the 
nation. The benefit in terms of life years saved per person would be greater among 
blacks relative to whites.
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moral Hazard and HEaltH inSurancE: Examining tHE rolE of PrivatE 
vS. PuBlic inSurancE in ProStatE cancEr ScrEEning, ProStatE cancEr 
diagonoSiS and PatiEnt SatiSfaction witH ProStatE cancEr carE
Zanwar P.
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Objectives: The objectives of the study were to compare the likelihood of prostate-
specific antigen (PSA) screening, the likelihood of prostate cancer diagnosis (in those 
who were PSA screened), and patient satisfaction (in those who received a prostate 
cancer diagnosis) in men covered by private vs. public insurance. MethOds: This 
was a retrospective cross-sectional study of U.S. men 40 to 85 years of age. A nation-
ally representative Medical Expenditure Panel Survey (MEPS) data on American 
households was utilized to identify all men by age and by insurance status for 
years 2002 to 2011. Results: Overall, 15202 men covered by any private insurance 
and 7409 men covered by any public insurance reported PSA screening within the 
last two years. Of these men, 751 covered by private insurance vs. 402 covered by 
public insurance received a diagnosis of prostate believed cancer within the last two 
years. In 2011, 102 men covered by private insurance vs. 59 men covered by public 
insurance reported a diagnosis of prostate cancer. In 2011, 77 men (or 75%) covered 
by private insurance vs. 28 men (or 47%) covered by public insurance reported they 
were covered by health insurance that paid for all part of the medical care, tests or 
cancer treatment, p= 0.058. Forty-seven men or (46%) covered by private insurance 
vs. 15 men (or 25%) covered by public insurance reported cancer will come back to 
them or get worse within the next ten years. cOnclusiOns: More men were likely 
to get PSA screened and diagnosed with prostate cancer if covered by private insur-
ance. More men covered by private insurance believed their insurance covered all 
the necessary prostate cancer care. However, more men covered by private insurance 
feared a relapse. The role of health insurance in cancer care trajectory and patient 
satisfaction with care needs further exploration.
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Objectives: Inadequate information is currently available about incidence and 
healthcare burden of cervical cancer among women enrolled in Medicaid. This 
study aimed to determine incidence of cervical cancer and associated healthcare 
resource utilization in a national managed care Medicaid population. MethOds: 
A case–control study design using the 2006–2008 Medicaid data from 38 states in 
the United States (US) was utilized. The study sample included women (≥ 18 years) 
with cervical cancer. A corresponding group of non–cancer controls was selected to 
determine the incremental healthcare burden of cervical cancer. Propensity scor-
ing technique was used to match cases and controls on a 1:2 ratio based on age, 
race, and geographic region. Inpatient (IP), outpatient (OT), and emergency room 
(ER) visits were calculated for cases and controls. Receipt of cervical cancer treat-
ment including radiation therapy, chemotherapy, and surgical procedures was also 
assessed. Descriptive analyses were conducted using SASv9.3. Results: The study 
sample comprised of 5,183 incident cases of cervical cancer and 10,366 non–cancer 
controls. Cases had significantly higher IP (0.42 vs. 0.21), OT (79.92 vs. 59.77), and ER 
(4.79 vs. 3.38) visits as compared to controls. Among cases, significantly higher IP 
visits were observed among women between 30 and 49 years of age. Black women 
had significantly greater IP visits (0.146) as compared to Whites (0.096) and other 
racial groups (0.143). Mean IP, OT and ER visits increased with stage of cervical 
cancer. Cervical colposcopy, conization, and radiation therapy were performed in 
34.52%, 28.00%, and 19.97% of the cases, respectively. cOnclusiOns: Despite being 
were systematically searched for comparative observational studies, randomised 
clinical trials and economic evaluations for periods up to October 2014. Studies 
comparing case management nurse intervention versus traditional care for can-
cer patients reporting outcomes of interest such as survival and quality of life, 
care management quality, hospital management were selected for further analy-
sis. Results: The search identified 1,899 publications for screening and 43 were 
selected for full text review, of which 20 publications were included and extracted. 
Majority of the studies were conducted in North America (N= 11). Sample size ranged 
between 100 and 1,200 patients. Only three studies reported survival data, among 
which only one study reported a significant higher survival for the intervention 
group. Eight studies reported outcomes related to quality of life and results were dif-
ferent depending on the population studied and scale used (i.e. EQ-5D, HUI3, EORTC-
QLQ-C30, FACT-G, FACT-C). Care management quality was assessed in five studies, 
reporting an overall better treatment management in the intervention group. Data 
relating hospital management was reported in 12 studies with various different 
results and four studies reported data related to costs, in which the type of costs, 
methodological aspects and results were very diverse. cOnclusiOns: Out of all 
the publications included, the overall conclusions of the authors show very diverse 
results regarding the impact of case management nurses on cancer patients. The 
heterogeneity of the results and the lack of outcomes on costs, especially in Europe 
compared to North America, demonstrate the need to conduct robust prospective 
studies and cost-analyses on case management nurses.
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Objectives: Based on an 13-years experience (1999-2012) in collecting and ana-
lyzing real-world data for the Italian Regulatory Agency, CINECA Interuniversity 
Consortium has developed an innovative Cloud-based IT platform for the 
entire management of Performance-based Risk Sharing arrangements among 
Pharmaceutical Companies and Payers/Regulatory Authorities. The system has 
been used for more than 70 innovative drugs from eleven registries: oncology, 
diabetes, neurology, orphan drugs, rheumatology and others. More than 500.000 
patients were registered by over 900 health structures (40.000 end-users) in a time-
frame of seven years. MethOds: Establish a unique and complete post-marketing 
safety surveillance and analysis system, used by Health Authorities (regional and 
national), Clinicians/Researchers and Payors which allows the management of 
performance-based risk-sharing arrangements (PBRSAs). The solution is designed 
to ensure proper data collection aimed to evaluate appropriateness , assess drug 
safety and estimate efficacy (automated procedures and calculations) in a real-
world context. Independently from the already existing solutions and organizational 
settings, the model allows to easily set-up ad-hoc procedures for data collections 
in any international context (multi-country and multi-language) supporting the 
implementation of PBRSAs for oncology (Payment by Results, Cost-Sharing and 
Risk-Sharing). Results: The platform is able to manage any value-based scheme 
agreed between manufacturers and payers and it also may support drug combina-
tions. By defining appropriate minimum datasets, with a limited effort, it is possible 
to involve all stakeholders obtaining systematic, homogeneous and high-quality 
data. Example of trastuzumab and trastuzumab+pertuzumab combination will be 
reported. cOnclusiOns: The introduction of an online integrated registry ensures 
the economic sustainability of innovative therapies and simplify their market 
access, while guaranteeing transparency of the whole process. It also ensures treat-
ment appropriateness, helps in monitoring drug consumption and related costs 
(better resources allocation), improves the real-time reporting of adverse events and 
allows the development of real-world datasets for scientific purposes.
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Objectives: Pakistan has very high maternal mortality ratio in South Asia. The 
high maternal mortality could be due to low prenatal care utilization and unsafe 
births. This analysis examines socioeconomic inequalities in prenatal care utiliza-
tion and investigates the association between the household economic status, other 
socio-demographic variables and prenatal care in Pakistan. MethOds: The study 
draws data from Pakistan Living Standards Measurement Survey (PLSM) conducted 
in both rural and urban areas of Pakistan in 2010-11. This analysis is based on 
4,177 married women of reproductive age i.e. 15-49 who gave birth during the past 
three years in Punjab and Sindh. Household economic status is measured using 
household annual consumption expenditures and households are categorized into 
quintiles. Results: There are regional disparities in prenatal care utilization in 
Pakistan. The proportion of women receiving prenatal care in rural areas is much 
lower than their urban fellows (65.3% vs. 83.6%). There is regional variation in seek-
ing prenatal care as well, as 83.1% in north Punjab, 77.9% in central Punjab and 
67.3% in south Punjab received prenatal care, whereas the proportion is 70.7% in 
southern Sindh and only 51.5% in north Sindh. The multivariate logistic regression 
results reveal that women of bottom three quintiles are significantly less likely to 
receive prenatal care compared to members of the highest quintile. Those residing 
in rural areas and in the north and south Sindh have a significant and negative 
association with receiving prenatal care compared to women residing in urban 
and central Punjab. cOnclusiOns: Public health programs focussing on improv-
ing the prenatal care utilization, particularly of poor women and those residing in 
rural areas need to be initiated. Low prenatal utilization could be associated with 
high health care cost. Interventions aiming at reduced health care cost for poor and 
rural women need to be initiated.
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more likely to have cardiovascular disease (61% vs. 40%), dyslipidemia (43% vs. 
29%), obesity (26% vs. 14%), and diabetes (22% vs. 17%, all p< 0.01) vs the gout-free 
cohort. Gout patients’ lab results (BMI, BP, eGFR, lipids) deviated from normal more 
than gout-free controls. Gout patients incurred a significantly higher number of 
annual physician visits (5 vs. 2.5), lab tests (24 vs. 4.5), and had a greater percentage 
with specialist referrals (58% vs. 46%, all p< 0.0001) leading to higher healthcare 
costs. cOnclusiOns: Gout is associated with high disease burden in a Canadian 
primary care setting, which is consistent with previous publications. Gout patients 
were more likely to have significant comorbidities, farther-from-normal lab results, 
and higher healthcare utilization and costs compared to gout-free patients.
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COMSATS Institute of Information Technology, Abbottabad, Pakistan
Objectives: The main objective of this study is to evaluate the prevalence of 
Meningitis in Hazara Division, KPK Pakistan MethOds: A retrospective approach 
was used to collect the data from Ayub Medical Complex Abbottabad Pakistan. 
Data collection was carried out from 2nd Feb to 1st May 2014, from Peadiatric 
ward. Results: A total of 360 patients were enrolled during the study in Ayub medi-
cal complex, Abbottabad, of which the meningitis patient were 40, occupying 11.11% 
of total admission in the Paeds wards. Male patient occupies the higher percentage 
of 61.38 % and female on the lesser side occupying only 38.51 %. The overall mortal-
ity rate during the study period was 12.22 % from all disease and from meningitis 
the mortality rate was 3.88 % from all the period. The mortality rate in meningitis 
patient was 35 % during the study period. cOnclusiOns: Meningitis either bac-
terial or viral is still a common serious infection. Both the causative (Bacterial or 
Viral) are common in the Hazara division of KPK. In our finding we have concluded 
that Meningitis prevalence is still more common and higher in Pakistan compare to 
other countries. Meningitis still prevail on higher side, so there is need of extensive 
awareness and vaccination program to cut down the prevalence rate. Meningitis 
Vaccination should be included in our expanded Immunization program (EPI).
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Objectives: In the US, antibiotic-resistant (ABR) pathogens infect > 2 million people 
and cause nearly 23,000 deaths annually. In 2013, the Centers for Disease Control 
and Prevention identified Clostridium difficile (C. diff), carbapenem-resistent 
Enterobacteriaceae (CRE), and drug-resistant Neisseria gonorrhoeae (N. gonor-
rhoeae) as the nation’s most urgent ABR threats. To understand the trajectory of 
ABR infections, we examined annual C. diff-, CRE-, and N. gonorrhoeae-related 
hospitalization and death rates in the US. MethOds: Data from the 2001-2012 
Healthcare Cost and Utilization Project’s National Inpatient Sample (NIS), nation-
ally representative surveys of US hospitalizations, were analyzed. Overall and age- 
and gender-stratified annual rates of C. diff-, CRE-, and N. gonorrhoeae-related 
hospitalizations (per 10,000 people) and deaths per 10,000 hospitalizations were 
calculated. Results: C. diff-related hospitalizations increased gradually from 5.2 
in 2001 to 11.9 in 2012. CRE-related hospitalizations more than doubled between 
2010 (5.6) and 2012 (11.9). N. gonorrhoeae-related hospitalizations remained fairly 
constant (0.2 in 2001 to 0.1 in 2012). C. diff-related hospitalizations among per-
sons aged 85+ increased substantially, from 55.7 in 2001 to a high of 113.3 in 2008. 
CRE-related hospitalizations were also highest for the 85+ age group. Females had 
substantially higher rates than males for all three pathogens over time. Death rates 
steadily increased for each pathogen during the study period. cOnclusiOns: C. 
diff- and CRE-related hospitalization rates have increased substantially over the 
past decade, while N. gonorrhoeae-related hospitalization rates remained constant. 
Both C. diff and CRE are commonly spread in healthcare settings; therefore, ris-
ing hospitalization rates with these infections is unsurprising. The recent surge in 
CRE-related hospitalizations is consistent with other studies that suggest increased 
use of carbapenems is partly responsible for increasing rates. These findings indi-
cate need for immediate attention to developing interventions to curb the growth 
of C. diff and CRE infections to reduce the burden on the patient population and 
healthcare system.
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Objectives: The aim of the present study is to evaluate the prevalence of several 
mental health diagnoses and utilization of anti-psychotic medications among the 
children (< 18 years) enrolled in the Mississippi Medicaid. MethOds: A retrospec-
tive analysis was conducted using Mississippi Medicaid administrative claims data 
for the period July 2013 to June 2014. Beneficiaries were included if enrolled in 
Medicaid (fee-for-service or coordinated care), were less than 18 years of age at 
end of observation year and enrolled 3+ months during the observation year. Since 
most mental health diagnoses are of a chronic nature, diagnosis were assessed 
using claims for the period January 2012 to June 2014 in order to be as complete as 
possible. Treatments and costs estimates were based on the one year observation 
period. Access to care was measured as the proportion of care received from MDs in-
county, in adjacent counties, and in other counties. All measures were computed for 
each county. Results: 387,838 children were identified in the observation period. 
Overall, the prevalence of ADHD (11.0%) was highest followed by developmental 
disorders (5.7%) and conduct disorder (4.4%). Children ages 11 to 18 had higher 
the easiest gynecological cancer to prevent, the study findings reveal a significant 
healthcare burden of cervical cancer in the national Medicaid population. A more 
rigorous routine screening of cervical cancer can be incorporated in clinical care of 
women enrolled in Medicaid to facilitate earlier diagnosis at pre–cancerous stage.
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Objectives: Noncommunicable diseases (NCDs) are the major global causes of 
morbidity and mortality. In Mongolia, a number of health policy documents have 
been developed targeting the prevention and control of noncommunicable diseases. 
This paper aimed to evaluate the extent to which NCD-related policies introduced 
in Mongolia align with the World Health Organisation 2008-2013 Action Plan for the 
Global Strategy for the Prevention and Control of NCDs (Action Plan). MethOds: We 
conducted a qualitative review of policy documents introduced by the Government 
of Mongolia from 2000 to 2013. A literature review, internet–based search, and expert 
consultation identified the policy documents. Information was extracted from the 
documents using a matrix, mapping each document against the six objectives of 
the Action Plan and five dimensions: data source, aim and objectives of document, 
coverage of conditions, coverage of risk factors and implementation plan. 40 NCD-
related policies were identified. Results: Prevention and control of the common 
NCDs and their major risk factors as described by WHO were widely addressed as 
were the objectives of the Action Plan. It appears that each objective of the WHO 
2008-2013 NCD Action Plan was well addressed. Many documents included explicit 
implementation or monitoring frameworks. Areas less well or/and not addressed 
were chronic respiratory disease, physical activity guidelines and dietary stand-
ards. cOnclusiOns: The Mongolian Government response to the emerging burden 
of NCDs is a population-based public health approach which includes a national 
multisectoral framework and integration of NCD prevention and control policies 
into national health policies. Our findings suggested gaps in addressing chronic res-
piratory disease, physical activity guidelines, specific food policy actions restricting 
sales advertising of food products, and a lack of funding specifically supporting NCD 
research. Future research should explore the effectiveness of national NCD policies 
and the extent to which the policies are implemented in practice.
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Objectives: Prostate cancer (PCa) claimed the lives of approximately 29,480 men 
in 2014 and American Cancer Society estimates the incidence of prostate cancer in 
2015 to be 220,800. Screening using the prostate specific antigen (PSA) test remains 
critical to the early detection and management of PCa. Our objective was to study 
the factors affecting PSA testing in the US for the year 2010. MethOds: We used 
the most recent National Ambulatory Medical Care Survey (NAMCS) data avail-
able which was for the year 2010. The NAMCS data is a nationally representative 
annual survey of the provision and utilization of outpatient medical care services 
in the US. Main outcome measure was undergoing the PSA test. A logistic regres-
sion model was fit to determine if any variables were associated with having the 
PSA test done. Results: Our weighted study sample consisted of primarily White 
men (N= 568,146,002) between the ages of 50-64 years (N= 231,848,274) residing in 
urban areas (N= 544,556,049) covered by private health insurance (N= 328,904,965) 
who were not being seen by a primary care provider (N= 381,639,557). Majority of 
the men had undergone a PSA test (N= 646,376,032). Multivariate analysis reveals 
that 65-79 years of age (OR: 3.4), living in urban areas (OR: 1.58), being consulted for 
chronic problems (OR: 2.25) and preventive services (OR: 4.40), being seen by surgical 
specialty physicians (OR: 1.52), and had private insurance (OR: 1.40) increased the 
likelihood of the visit resulting in a PSA test. cOnclusiOns: Contrary to expected 
standard of practice of primary care physician (PCP) visits influencing PSA testing, 
our study showed that visiting with a surgeon increased the likelihood of PSA test-
ing. Providing patients with the opportunity to be tested as early as possible during 
their visit with a PCP might aid in efficiently diagnosing PCa.
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Objectives: Gout, a common arthritis, causes significant burden on patient’s 
quality of life and the health-care system. The objectives of this study were to 
understand a gout population in terms of demographics, clinical characteristics, 
healthcare utilization and costs versus a gout-free population. MethOds: This 
retrospective study is one portion of an overall gout study, which used data extracted 
from IMS Evidence 360 EMR Canada, a primary care electronic medical records data-
base in Ontario. Gout patients were selected if they had ≥ 1 gout diagnosis and/or ≥ 1 
gout medication claim (index date) from 1 July 2008 to 30 June 2012. Gout patients 
were matched 1:5 to gout-free patients based on demographics and comorbidities 
using an adapted version of the Charlson Comorbidity Index (CCI). All patients were 
followed for two years post-index date. Costs were limited to primary care physician 
visits. Results: There were 676 gout patients; 77% were male with mean age of 58 
years, which matched closely to gout-free patients. Mean CCI score at baseline was 
1.08 in both groups. Over the two-year follow-up, gout patients were significantly 
